Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.49 |
| ▸ | KDM4A | O75164 | 1/20 | 0.49 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.49 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31206980 | 0.91 | KDM4C (0.53) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL15660100 | 0.91 | KDM4C (0.53) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL10658512 | 0.89 | LMNA (0.61) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL10894160 | 0.89 | LMNA (0.61) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL5656727 | 0.89 | LMNA (0.61) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL5196828 | 0.88 | LMNA (0.50) | LMNAFFAR4FFAR1FAAHMAPT | |
| SCHEMBL8782041 | 0.84 | KDM4C (0.48) | KDM4CKDM4APHF8KDM2AFFAR4 | |
| SCHEMBL3636046 | 0.81 | LMNA (0.67) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL487067 | 0.81 | LMNA (0.46) | KDM4CKDM4APHF8KDM2ALMNA | |
| SCHEMBL23521354 | 0.80 | MAPT (0.49) | LMNAFFAR4FFAR1FAAHMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100372919-C | Surfactant composition | KAO CORP (JP) | 2008-03-05 | — | — | CN | disclosed |
| CN-1215159-C | Surfactant composition | KAO CORP (JP) | 2005-08-17 | — | — | CN | disclosed |
| CN-1377947-A | Surfactant composition | KAO CORP (JP) | 2002-11-06 | — | — | CN | disclosed |
| US-6407054-B2 | Surfactant composition | KAO CORPORATION (JP) | 2002-06-18 | — | — | US | disclosed |
| CN-1339059-A | Surfactant composition | KAO CORP (JP) | 2002-03-06 | — | — | CN | disclosed |
| US-20010034310-A1 | Surfactant composition | KAO CORPORATION (JP) | 2001-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010034310-A1 | Surfactant composition | DEGS1, SGMS1, LIPA | KDM4C 3855/4885KDM4A 4094/4885PHF8 848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.